Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6607)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2014 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Grassi A, Ballardini G. Post-liver transplant hepatitis C virus recurrence: An unresolved thorny problem. World J Gastroenterol 2014; 20(32): 11095-11115 [PMID: 25170198 DOI: 10.3748/wjg.v20.i32.11095] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v20/i32/11095.htm |
| Number | Citing Articles |
| 1 |
Tomasz Cieciura, Arkadiusz Urbanowicz, Bartosz Foroncewicz, Ewa Hryniewiecka, Leszek Pączek, Michał Ciszek. Hepatocellular Carcinoma Is a Negative Predictor of Sustained Viral Response in Liver Transplant Recipients With Hepatitis C Treated With Direct-Acting Antivirals. Transplantation Proceedings 2020; 52(8): 2450 doi: 10.1016/j.transproceed.2020.01.098
|
| 2 |
Mohamed Abdel-Wahab, Ehab E. Abdel-Khalek, Abdel-Hady El-Gilany, Amr M. Yassen, Mohamed Al-Shobari, Usama Shiha, Mahmoud Ali, Mohamed Sadani, Tarek Salah, Ahmad M. Sultan, Ahmed N. Elghawalby, Mohamed Elmorshedi, Al-Refaey K. Al-Refaey, Usama Abdalla. Predictors of hepatitis C virus recurrence after living donor liver transplantation: Mansoura experience. Arab Journal of Gastroenterology 2017; 18(3): 151 doi: 10.1016/j.ajg.2017.09.006
|
| 3 |
Nicole B. Leonard, Gillian L. Hale, Katherine E. Boylan, Zhining Ou, Chong Zhang, Robin Kim, Shaun Chandna, Zachary M. Dong, Kimberley J. Evason. Histologic features of allograft livers in patients treated for rejection before biopsy. Human Pathology 2023; 135: 11 doi: 10.1016/j.humpath.2023.02.005
|
| 4 |
Fabio Baganate, Eliza W. Beal, Dmitry Tumin, Daniel Azoulay, Khalid Mumtaz, Sylvester M. Black, Kenneth Washburn, Timothy M. Pawlik. Early mortality after liver transplantation: Defining the course and the cause. Surgery 2018; 164(4): 694 doi: 10.1016/j.surg.2018.04.039
|
| 5 |
M. Berenguer, K. Agarwal, P. Burra, M. Manns, D. Samuel. The road map toward an hepatitis C virus-free transplant population. American Journal of Transplantation 2018; 18(10): 2409 doi: 10.1111/ajt.14976
|
| 6 |
Satheesh P. Nair, Hemnishil K. Marella, Benedict Maliakkal, Heather Snyder, Charlotte Handley, Jiten P. Kothadia, Bilal Ali, Sanjaya K. Satapathy, Miklos Z. Molnar, Ian Clark, Richa Jain, Ryan Helmick, Corey Eymard, James D. Eason. Transplantation of liver from hepatitis C–infected donors to hepatitis C RNA–negative recipients: Histological and virologic outcome. Clinical Transplantation 2021; 35(5) doi: 10.1111/ctr.14281
|
| 7 |
Humberto Bohorquez, Emily Bugeaud, Natalie Bzowej, Jennifer Scheuermann, Jonathan Hand, David Bruce, Ian Carmody, Ari Cohen, Shobha Joshi, John Seal, Dennis Sonnier, George Therapondos, Nigel Girgrah, Stephanie Anders, George E. Loss. Liver Transplantation Using Hepatitis C Virus–Viremic Donors Into Hepatitis C Virus–Aviremic Recipients as Standard of Care. Liver Transplantation 2021; 27(4): 548 doi: 10.1002/lt.25925
|
| 8 |
Dipesh Kumar Yadav, Rajesh Kumar Yadav, Tingbo Liang. Controversies in Liver Transplantation - Recent Challenges and Future Perspectives. 2023; doi: 10.5772/intechopen.108906
|
| 9 |
Norbert Grüner, A. Gerbes. Direkter Angriff auf das Hepatitis-C-Virus. MMW - Fortschritte der Medizin 2015; 157(8): 57 doi: 10.1007/s15006-015-3035-0
|
| 10 |
|
| 11 |
Madhumitha Rabindranath, Rita Zaya, Khairunnadiya Prayitno, Ani Orchanian-Cheff, Keyur Patel, Elmar Jaeckel, Mamatha Bhat. A Comprehensive Review of Liver Allograft Fibrosis and Steatosis: From Cause to Diagnosis. Transplantation Direct 2023; 9(11): e1547 doi: 10.1097/TXD.0000000000001547
|
| 12 |
Renato Romagnoli, Silvia Martini, Francesco Tandoi, Dominic Dell Olio, Paola Magistroni, Francesca E. Bertinetto, Ennia Dametto, Mario Rizzetto, Mauro Salizzoni, Antonio Amoroso. Early reduced liver graft survival in hepatitis C recipients identified by two combined genetic markers. Transplant International 2016; 29(10): 1070 doi: 10.1111/tri.12795
|
| 13 |
|
| 14 |
Sarah Burgess, Nilufar Partovi, Eric M. Yoshida, Siegfried R. Erb, Vladimir Marquez Azalgara, Trana Hussaini. Drug Interactions With Direct-Acting Antivirals for Hepatitis C. Annals of Pharmacotherapy 2015; 49(6): 674 doi: 10.1177/1060028015576180
|
| 15 |
James M. Neuberger, Wolf O. Bechstein, Dirk R.J. Kuypers, Patrizia Burra, Franco Citterio, Sabina De Geest, Christophe Duvoux, Alan G. Jardine, Nassim Kamar, Bernhard K. Krämer, Herold J. Metselaar, Frederik Nevens, Jacques Pirenne, Manuel L. Rodríguez-Perálvarez, Didier Samuel, Stefan Schneeberger, Daniel Serón, Pavel Trunečka, Giuseppe Tisone, Teun van Gelder. Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients. Transplantation 2017; 101(4S): S1 doi: 10.1097/TP.0000000000001651
|
| 16 |
Chih-Yang Hsiao, Ming-Chih Ho, Cheng-Maw Ho, Yao-Ming Wu, Po-Huang Lee, Rey-Heng Hu. Long-Term Tacrolimus Blood Trough Level and Patient Survival in Adult Liver Transplantation. Journal of Personalized Medicine 2021; 11(2): 90 doi: 10.3390/jpm11020090
|
| 17 |
Claire Gondeau, Georges Philippe Pageaux, Dominique Larrey. Hepatitis C virus infection: Are there still specific problems with genotype 3?. World Journal of Gastroenterology 2015; 21(42): 12101-12113 doi: 10.3748/wjg.v21.i42.12101
|
| 18 |
Kimberly A. Brown, Mona Hassan. Utilizing Donors with Hepatitis C Antibody Positivity and Negative Nucleic Acid Testing. Current Transplantation Reports 2018; 5(4): 327 doi: 10.1007/s40472-018-0218-5
|
| 19 |
Sonia Samuel, Ahmad Abulawi, Raza Malik. Hepatitis C and Nonalcoholic Steatohepatitis in the 21st Century: Impact on Liver Disease and Liver Transplantation. Gastroenterology Insights 2023; 14(3): 249 doi: 10.3390/gastroent14030018
|
| 20 |
Jonathan Merola, Alexander Z. Jow, Samuel H. Sigal. Principles and Practice of Transplant Infectious Diseases. 2019; : 697 doi: 10.1007/978-1-4939-9034-4_41
|
| 21 |
Jennifer Keller, Gary Marklin, Obi Okoye, Roshani Desai, Tej Sura, Ajay Jain, Chintalapati Varma, Mustafa Nazzal, Simon C. Robson. Treatment of Hepatitis C Post-Liver Transplantation Could Mitigate Discard Rates of Hepatitis C-Positive Deceased Donor Livers and Expand the Donor Pool. Journal of Transplantation 2021; 2021: 1 doi: 10.1155/2021/6612453
|
| 22 |
Hung‐Tien Kuo, Erik Lum, Paul Martin, Suphamai Bunnapradist. Effect of diabetes and acute rejection on liver transplant outcomes: An analysis of the organ procurement and transplantation network/united network for organ sharing database. Liver Transplantation 2016; 22(6): 796 doi: 10.1002/lt.24414
|
| 23 |
Hafsa Aziz, Shazia Fatima, Mohammad Faheem. Indeterminate Prediction of Hepatitis C Virus Genotype by Commercial Real-Time Polymerase Chain Reaction Assay Resolving by Sequencing to Avoid the Consequence of Inaccurate Typing. Viral Immunology 2020; 33(7): 507 doi: 10.1089/vim.2019.0162
|
| 24 |
Jong Man Kim, Kwang-Woong Lee, Gi-Won Song, Bo-Hyun Jung, Hae Won Lee, Nam-Joon Yi, Choon Hyuck David Kwon, Shin Hwang, Kyung-Suk Suh, Jae-Won Joh, Suk-Koo Lee, Sung-Gyu Lee. Increased survival in hepatitis c patients who underwent living donor liver transplant: a case-control study with propensity score matching. Annals of Surgical Treatment and Research 2017; 93(6): 293 doi: 10.4174/astr.2017.93.6.293
|
| 25 |
Nikolaos Pyrsopoulos, Panagiotis Trilianos, Vivek A. Lingiah, Phoenix Fung, Merlin Punnoose. The safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in the treatment of orthotopic liver transplant recipients with recurrent hepatitis C: real-world data. European Journal of Gastroenterology & Hepatology 2018; 30(7): 761 doi: 10.1097/MEG.0000000000001101
|
| 26 |
Reham M. Dawood, Ghada M. Salum, Mai Abd El-Meguid, Mohamed Shemis, Ashraf O. Abdel Aziz, Mostafa K. El Awady. Recipient interleukin 6 gene polymorphism and expression predict HCV recurrence post liver transplantation. Gene 2020; 754: 144887 doi: 10.1016/j.gene.2020.144887
|
| 27 |
Shu-Hsien Lin, Kun-Ta Wu, Chih-Chi Wang, Kuang-Tzu Huang, Li-Wen Hsu, Hock-Liew Eng, King-Wah Chiu. Immune Responses to Anti-Hepatitis C Virus Antibodies during Pre-Liver Transplantation Direct-Acting Antiviral Therapy in Hepatitis C Virus-Infected Recipients Associated with Post-Liver Transplantation Allograft Injury. Antibodies 2024; 13(1): 7 doi: 10.3390/antib13010007
|
| 28 |
O. M. Tsiroulnikova, D. V. Umrik. Antiviral therapy of hepatitis C with 1 genotype after liver transplantation. Russian Journal of Transplantology and Artificial Organs 2018; 20(3): 105 doi: 10.15825/1995-1191-2018-3-105-115
|
| 29 |
Emiliano Dalla, Michela Bulfoni, Daniela Cesselli, Riccardo Pravisani, Masaaki Hidaka, Susumu Eguchi, Umberto Baccarani. Reinfection of Transplanted Livers in HCV- and HCV/HIV-Infected Patients Is Characterized by a Different MicroRNA Expression Profile. Cells 2022; 11(4): 690 doi: 10.3390/cells11040690
|